Market World Cardiac Biomarkers Market Outlook | Page 3

Regional Insights
The regional market considered in the cardiac biomarkers sector are North America, Europe, Asia Pacific, Latin
America, and MEA. North America is estimated to account for the largest revenue share in 2015. The high
prevalence of the cardiac disorders in the North America has boosted the application of cardiac biomarkers in
North America. Moreover, the increasing popularity of the PoC testing has added to the growth of the market.
The Asia Pacific region is anticipated to witness fastest growth owing to large population base with target
disease. The high prevalence of the cardiovascular diseases has augmented the cardiac biomarker products in
the Asia Pacific region. The major emerging markets such as India and China attributes for the major growth in
the cardiac biomarker segment in the Asia Pacific region.
Competitive Insights
The major players in the cardiac biomarker market include Roche Diagnostics; Siemens Healthcare; Alere, Inc.;
Beckman Coulter, Inc.; Thermo Fisher Scientific, Inc.; Bio-Rad Laboratories, Inc.; Becton, Dickinson and
Company; bioMérieux SA; and Randox Laboratories Ltd.
The new product launches and increasing development in the products are major growth trends in the cardiac
biomarker market. The rising demand for efficient and rapid diagnostics of cardiovascular diseases is the key
contributing factor to the sector growth. Alere triage panel, manufactured by Alere, Inc., is a combination of
three major biomarkers namely, CK-MB, myoglobin, and troponin I. The test is handy due to efficient detection
of the cardiovascular disease and, being a combination product, there is a great demand for the test in the
market.
Market Segment:
Cardiac Biomarkers Type Outlook (Revenue, USD Million, 2013 - 2024)
• Troponin
• CK-MB
• Natriuretic peptides - BNP and NT-proBNP
• Myoglobin
• Others
Cardiac Biomarkers Market Application Outlook (Revenue, USD Million, 2013 - 2024)
• Acute Coronary Syndrome